Hormonstatus Frau (Female Hormone Panel)

Comprehensive female reproductive hormone panel for women of childbearing age analyzing 10 hormones regulating menstrual cycles, fertility, ovulation, mood, metabolic health, and ovarian reserve. Venous blood sample with critical timing - ideally Day 3-5 of menstrual cycle for FSH/LH/estradiol/AMH (early follicular phase), Day 21 for progesterone (mid-luteal phase, or 7 days before expected period). Results within 3-5 days. Essential for: irregular periods, fertility issues, PCOS investigation, unexplained weight gain, mood disorders, low libido, PMS symptoms, perimenopause concerns, assessing ovarian reserve before fertility treatment. Biomarkers tested: FSH (follicle-stimulating hormone) - controls ovarian follicle maturation and egg development, Day 3 FSH levels predict ovarian reserve (low reserve if FSH >10-15 IU/L, approaching menopause if >25 IU/L), very high FSH (>40 IU/L) indicates ovarian failure/menopause, cyclic FSH rises select dominant follicle for ovulation; LH (luteinizing hormone) - triggers ovulation mid-cycle releasing mature egg, LH:FSH ratio diagnostic for PCOS (ratio >2:1 suggests PCOS with multiple small follicles and anovulation), absent LH surge indicates anovulation (no ovulation occurring); Estradiol (E2) - primary estrogen hormone, regulates menstrual cycle, maintains endometrium, bone density, cardiovascular health, brain function, libido, skin/hair quality, Day 3 levels should be low (<50-80 pg/mL for normal ovarian function, elevated Day 3 estradiol suggests diminished ovarian reserve or ovarian cyst), rises during follicular phase peaking just before ovulation, low estradiol causes irregular periods, hot flashes, vaginal dryness, bone loss; Progesterone - produced by corpus luteum after ovulation, maintains early pregnancy, balances estrogen, thickens endometrium for implantation, Day 21 progesterone confirms ovulation occurred (levels >10 ng/mL indicate ovulation, <10 ng/mL suggest anovulation or luteal phase defect causing infertility/miscarriage), low progesterone causes irregular bleeding, PMS, anxiety, insomnia; Testosterone - androgen affecting libido, energy, muscle mass, mood in women, mildly elevated testosterone common in PCOS (along with high LH:FSH ratio), very high testosterone suggests other androgen excess disorders; SHBG (sex hormone-binding globulin) - binds testosterone and estrogen, low SHBG (from insulin resistance, obesity, PCOS) increases free androgens worsening PCOS symptoms (acne, hirsutism, hair loss); Prolactin - elevated prolactin (>25 ng/mL) suppresses GnRH release causing anovulation, irregular periods, infertility, galactorrhea, caused by prolactinoma, medications, hypothyroidism, stress; TSH (thyroid stimulating hormone) - thyroid dysfunction causes menstrual irregularities, anovulation, infertility, both hypothyroidism (irregular heavy periods, weight gain) and hyperthyroidism (light/absent periods, weight loss) disrupt reproduction; DHEA-S (dehydroepiandrosterone sulfate) - adrenal androgen, elevated DHEA-S suggests adrenal androgen excess vs ovarian source, helpful differentiating PCOS from adrenal disorders; AMH (anti-Müllerian hormone) - gold standard ovarian reserve marker, produced by small follicles in ovaries, directly correlates with remaining egg supply, levels <1.0 ng/mL indicate low reserve, <0.5 ng/mL severely diminished, undetectable AMH suggests menopause imminent, unlike FSH/estradiol AMH does not fluctuate with menstrual cycle providing stable reserve assessment. Panel identifies: PCOS (high LH:FSH ratio, high testosterone/DHEA-S, low SHBG, anovulation), diminished ovarian reserve (high FSH, low AMH, high Day 3 estradiol), hypothalamic amenorrhea (low all hormones from stress/low weight/overexercise), hyperprolactinemia (high prolactin), thyroid dysfunction (abnormal TSH), luteal phase defect (low progesterone). Results guide: fertility treatment planning (AMH/FSH predict IVF response), PCOS management (metformin, spironolactone, OCP), ovulation induction (clomiphene, letrozole if anovulatory), progesterone supplementation (luteal phase support), thyroid treatment, prolactinoma investigation. Recommended: baseline fertility assessment late 30s/early 40s, investigating irregular cycles/infertility, every 6-12 months monitoring PCOS, annually perimenopause transition. GOÄ pricing €248.03. Most comprehensive female hormone panel available.

A hormone panel measures the chemical messengers that regulate virtually every function in your body — from energy and mood to metabolism, sleep, reproduction, and muscle growth. Hormones fluctuate with age, stress, sleep quality, and lifestyle, and imbalances can cause symptoms that are often attributed to "just getting older." Common markers include testosterone and estradiol (sex hormones), cortisol (the stress hormone), DHEA-S (an adrenal precursor), thyroid hormones, and gonadotropins like FSH and LH that regulate reproductive function. Men typically see testosterone decline after 30, while women experience significant hormonal shifts during perimenopause and menopause. Testing provides objective data to distinguish hormonal issues from other causes.